BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14669536)

  • 1. [The effects of tamoxifen on the female genital tract].
    Mourits MJ; van der Zee AG; Willemse PH; Hollema H; de Vries EG
    Ned Tijdschr Geneeskd; 2003 Nov; 147(47):2315-20. PubMed ID: 14669536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen treatment and gynecologic side effects: a review.
    Mourits MJ; De Vries EG; Willemse PH; Ten Hoor KA; Hollema H; Van der Zee AG
    Obstet Gynecol; 2001 May; 97(5 Pt 2):855-66. PubMed ID: 11336777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian cysts in women receiving tamoxifen for breast cancer.
    Mourits MJ; de Vries EG; Willemse PH; ten Hoor KA; Hollema H; Sluiter WJ; de Bruijn HW; van der Zee AG
    Br J Cancer; 1999 Apr; 79(11-12):1761-4. PubMed ID: 10206289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of tamoxifen on the female genital tract.
    Senkus-Konefka E; Konefka T; Jassem J
    Cancer Treat Rev; 2004 May; 30(3):291-301. PubMed ID: 15059652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of raloxifene on other organs without bone: uterus].
    Nozaki M
    Clin Calcium; 2004 Oct; 14(10):55-60. PubMed ID: 15577132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial changes with chronic tamoxifen use.
    Loret de Mola JR
    Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tamoxifen: does a wider range of indications require more careful monitoring?].
    Vogel NE; ter Brugge HG; de Graaf JC; Pierik EG
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1041-3. PubMed ID: 11414162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract.
    Cohen CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-55-S1-64. PubMed ID: 9045317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
    Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
    Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
    Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
    Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aminoglutethimide plus hydrocortisone on the genital tract of postmenopausal women with advanced breast cancer. A clinical and cytologic survey.
    Budel VM; Paridaens RJ; Spetschinsky A; Heuson JC; Gompel C
    Anticancer Res; 1986; 6(4):709-12. PubMed ID: 3752949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cyst formation in patients using tamoxifen for breast cancer.
    Metindir J; Aslan S; Bilir G
    Jpn J Clin Oncol; 2005 Oct; 35(10):607-11. PubMed ID: 16254040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen on the human female genital tract: review of the literature.
    Varras M; Polyzos D; Akrivis Ch
    Eur J Gynaecol Oncol; 2003; 24(3-4):258-68. PubMed ID: 12807236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.